M1 Medulloblastoma: high risk at any age

Item

http://www.wikidata.org/entity/Q37003627

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 15 August 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

M1 Medulloblastoma: high risk at any age

@en

M1 Medulloblastoma: high risk at any age.

@nl

type

Item

label

M1 Medulloblastoma: high risk at any age

@en

M1 Medulloblastoma: high risk at any age.

@nl

prefLabel

M1 Medulloblastoma: high risk at any age

@en

M1 Medulloblastoma: high risk at any age.

@nl

P1476

M1 Medulloblastoma: high risk at any age

@en

P2093

Alberto Broniscer

http://www.w3.org/2001/XMLSchema#string

Amar Gajjar

http://www.w3.org/2001/XMLSchema#string

Arzu Onar

http://www.w3.org/2001/XMLSchema#string

E Brannon Morris

http://www.w3.org/2001/XMLSchema#string

Frederick A Boop

http://www.w3.org/2001/XMLSchema#string

Gregory T Armstrong

http://www.w3.org/2001/XMLSchema#string

Ibrahim Qaddoumi

http://www.w3.org/2001/XMLSchema#string

James M Boyett

http://www.w3.org/2001/XMLSchema#string

Larry E Kun

http://www.w3.org/2001/XMLSchema#string

Robert A Sanford

http://www.w3.org/2001/XMLSchema#string

P2860

Multiagent chemotherapy and deferred radiotherapy in infants with malignant brain tumors: a report from the Children's Cancer Group

Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: conclusions from the Children's Cancer Group 921 randomized phase III study.

The treatment of malignant brain tumors in infants and very young children: an update of the Pediatric Oncology Group experience.

Postoperative neoadjuvant chemotherapy before radiotherapy as compared to immediate radiotherapy followed by maintenance chemotherapy in the treatment of medulloblastoma in childhood: results of the German prospective randomized trial HIT '91.

Feasibility and response to induction chemotherapy intensified with high-dose methotrexate for young children with newly diagnosed high-risk disseminated medulloblastoma.

Survival of infants with primitive neuroectodermal tumors or malignant ependymomas of the CNS treated with eight drugs in 1 day: a report from the Childrens Cancer Group.

Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial.

Phase I clinical trial of mafosfamide in infants and children aged 3 years or younger with newly diagnosed embryonal tumors: a pediatric brain tumor consortium study (PBTC-001).

Treatment of early childhood medulloblastoma by postoperative chemotherapy alone.

Postoperative chemotherapy and delayed radiation in children less than three years of age with malignant brain tumors.

P2888

s11060-008-9671-9

P304

351-355

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11060-008-9671-9

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2008-08-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

227217482

http://www.w3.org/2001/XMLSchema#string

P698

18704266

http://www.w3.org/2001/XMLSchema#string

P921

medulloblastoma

P932

2597631

http://www.w3.org/2001/XMLSchema#string